SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer gets MIDC’s nod for transfer of business undertaking to Vidhi

05 Jul 2019 Evaluate

Pfizer has received approval from MIDC for the transfer of the business undertaking to Vidhi Research and Development LLP (Vidhi). The business undertaking includes the land, plant & machinery and employees, save and except certain portion of the land.

Earlier, the company had entered into Business Transfer Agreement for transfer of the Company’s business undertaking at Thane (BTA) as a going concern to Vidhi for a lump sum consideration of Rs 178 crore.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4891.60 -62.45 (-1.26%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×